Nanocarriers can be divided into two principal groups: organic and inorganic types. The organic group contains lipid nanocarriers, liposomes, polymeric nanoparticles, dendrimers, etc. In the case of the carriers in this group, the limited volume of delivered active pharmaceutical ingredient (API) is a clear disadvantage, along with decreased stability, and good sensitivity to temperature, pH, and enzymes in a physiological environment. The inorganic group contains metal oxide-, carbon-, silicon-, silica-, and quantum dot-based nanocarriers. Their benefits are greater stability and well-tunable physicochemical properties, but their accumulation in the body may be a key question of their applicability. Silica nanoparticles (SNP) are silicon dioxide (SiO 2 ) nanoparticles in an amorphous state and have excellent potential in the pharmaceutical industry and drug development due to their special properties. According to pore size, the most common, most well-liked, and most effective type of silica nanocarriers are the mesoporous silica nanoparticles (MSNs) [ 1 ].
What Is the Density of Silica? Values for Quartz, Fused and Amorphous Silica
Silica COA: What a Certificate of Analysis Should Include and How to Verify It
Sibelco Quartz: Product Range, Purity Grades and Applications
Monocrystalline Silicon vs Silica: How Silicon Wafers Are Made from Quartz
Silica Supplier Korea: Key Producers, Demand Sectors and Import Options
Calcium Carbonate Filler vs Silica: Performance, Cost and Applications Compared
What is silica (SiO₂)?
E551
72. García-Fernández A., Sancho M., Bisbal V., Amorós P., Marcos M.D., Orzáez M., Sancenón F., Martínez-Máñez R. Targeted-lung delivery of dexamethasone using gated mesoporous silica nanoparticles. A new therapeutic approach for acute lung injury treatment. J. Control. Release. 2021;337:14-26. doi: 10.1016/j.jconrel.2021.07.010. [ DOI ] [ PubMed ] [ Google Scholar ]
What is the difference between fumed silica and precipitated silica?
porous silica
What drives silica raw material prices?
silica for coatings
55. Antonino R.S., Ruggiero M., Song Z., Nascimento T.L., Lima E.M., Bohr A., Knopp M.M., Löbmann K. Impact of drug loading in mesoporous silica-amorphous formulations on the physical stability of drugs with high recrystallization tendency. Int. J. Pharm. X. 2019;1:100026. doi: 10.1016/j.ijpx.2019.100026. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]
Cite this article: Silica Raw Materials News. "Silicon Dioxide CAS 7631-86-9: Identification, Properties and Regulatory Information
." Published 2026-11-20 10:36:56. /news/article.html Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.